Alireza Javadi

CIK: 0002123843

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (25.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (25.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

RANI

Rani Therapeutics Holdings, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (4 total)

RANI
Rani Therapeutics Holdings, Inc.
Sep 27, 2026
Tax Payment(F)
Direct
309 shares at avg. $0.76$234.593
RANI
Rani Therapeutics Holdings, Inc.
Jun 27, 2026
Tax Payment(F)
Direct
309 shares at avg. $0.74$228.66
RANI
Rani Therapeutics Holdings, Inc.
Jun 3, 2026
Award(A)
Stock Option (Right to Buy)
Direct
805.5K shares-
RANI
Rani Therapeutics Holdings, Inc.
Mar 27, 2026
Sale(S)
Direct
386 shares at avg. $0.78$301.08

		Type	Shares	Price		Ownership
Sep 27, 2026	RANI Rani Therapeutics Holdings, Inc.	Tax Payment(F)	309	$0.76	$235	Direct
Jun 27, 2026	RANI Rani Therapeutics Holdings, Inc.	Tax Payment(F)	309	$0.74	$229	Direct
Jun 3, 2026	RANI Rani Therapeutics Holdings, Inc.	Award(A) Stock Option (Right to Buy)	805,500	-	-	Direct
Mar 27, 2026	RANI Rani Therapeutics Holdings, Inc.	Sale(S)	386	$0.78	$301	Direct

1-4 of 4 transactions

About Javadi Alireza

Javadi Alireza (SEC CIK 0002123843) files insider reports with the SEC as Chief Technical Officer of Rani Therapeutics Holdings, Inc. (RANI).

Signal8 holds 4 ownership filings by Javadi Alireza (1 Form 3, 3 Form 4), filed between Mar 27, 2026 and Sep 29, 2026. Those filings report 4 transactions, from Mar 27, 2026 to Sep 27, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Javadi Alireza's filings is in SAN JOSE, CA.

Recent filings by Javadi Alireza

Sep 27, 2026: Tax withholding of RANI shares (Form 4, code F).
Jun 27, 2026: Tax withholding of RANI shares (Form 4, code F).
Jun 3, 2026: Grant or award of RANI derivative securities (Form 4, code A).
Mar 27, 2026: Open-market sale of RANI shares (Form 4, code S).

Other insiders filing for Rani Therapeutics Holdings, Inc. (RANI)

Imran Talat, Chief Executive Officer
Gilson Michelle, Director
IMRAN MIR A, Director
Maestas Nicholas, Chief Financial Officer
McKinley Kate, Chief Business Officer
Bassan Abraham, Director

How to read Form 4 transaction codes